Anti-Human CD27 Ligand/TNFSF7/CD70 Reference Antibody (BMS936561, RUO)
Overview
| Catalog No. |
HW717046 |
| Brand |
abinScience |
| Host species |
Human |
| Species reactivity |
Human |
| Form |
Liquid |
| Storage buffer |
0.01M PBS pH 7.4 |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Clonality |
Monoclonal |
| Isotype |
IgG |
| Applications |
ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target |
CD27 ligand, CD70, TNFSF7, CD27LG, CD27L, CD70 antigen, Tumor necrosis factor ligand superfamily member 7, CD27-L |
| References |
1. Owonikoko TK, et al. First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Cancer Chemother Pharmacol. 2016 Jan;77(1):155-62. [HW717046] |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Biological activity |
CD70 (TNFSF7) is a type II transmembrane glycoprotein belonging to the tumor necrosis factor superfamily and serves as the specific ligand for CD27. It mediates T and B cell activation, proliferation, and immune regulation; notably, it is aberrantly overexpressed in various tumors, making it a highly promising target for cancer immunotherapy. |
| Endotoxin level |
< 10 EU/mg |
| Expression system |
Mammalian cells |
| Accession |
P32970 |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | BMS936561, MDX-1115, MDX-1203 |
| Clone ID | BMS936561 |
| Product Usage Information |
| Application | Dilution |
|---|
| ELISA | 1:2000-1:20000 |
|
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
Images
 SDS-PAGE |
SDS-PAGE for Research Grade Anti-Human CD70 (BMS936561) |